Companies
AS
NikkeiHealth Care· Japan

4503

Astellas Pharma

$2,570.00

+0.65%

Open $2,578.00·Prev $2,553.50

Delayed

ANALYSIS PENDING

Power Core

Structural analysis in progress

Published
UniverseNikkei 225
SectorHealth Care

Direction of Movement

---

ROC 200

+82.7%

Coverage In Progress

Power Mapping analysis for Astellas Pharma is scheduled for publication as part of the Nikkei 225 rollout.

Nikkei 225 coverage: Q4 2026
Sign up to get notified
This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.